LYTIR

Company · MRNA

Moderna, Inc.

Nasdaq's symbol directory lists MRNA on Nasdaq as “Moderna, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 15 occasions ($89.3M); 11 planned-sale notices; 4 filings by holders of 5% or more; 12 congressional trade disclosures; 7 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 46, No. 27, No. 26, No. 17

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $89.3M in total.May: Insider sales $3.3MJun: Insider sales $2.9MJul: Insider sales $3.6MAug: Insider sales $28.7MSep: Insider sales $16.9MOct: Insider sales $17.0MNov: Insider sales $16.9MDecJanFebMarAprMayJunJulAugSepOctNov$28.7M
Insider purchases above the line: $0Insider sales below: $89.3M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Hoge Stephen, President sold on 9 days all under a 10b5-1 plan latest Nov 17, 2026 sold $54.5M
  2. Bancel Stephane, Chief Executive Officer sold on 1 day all under a 10b5-1 plan latest Aug 5, 2026 sold $28.7M
  3. Mock James M, Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Sep 10, 2026 sold $4.7M
  4. Klinger Shannon Thyme, Chief Legal Officer sold on 2 days all under a 10b5-1 plan latest Sep 1, 2026 sold $659K
  5. AFEYAN NOUBAR sold on 1 day latest May 21, 2026 sold $434K
  6. Hussain Abbas sold on 1 day all under a 10b5-1 plan latest May 1, 2026 sold $265K
Every trade (15)
  1. SELLHoge Stephen, President sold Nov 17, 2026 39,215 shares 3 legs combined 10b5-1 plan (scheduled) filing $8.3M
  2. SELLHoge Stephen, President sold Nov 16, 2026 39,160 shares 10b5-1 plan (scheduled) filing $8.6M
  3. SELLHoge Stephen, President sold Oct 15, 2026 39,145 shares 10b5-1 plan (scheduled) filing $8.6M
  4. SELLHoge Stephen, President sold Oct 14, 2026 39,224 shares 2 legs combined 10b5-1 plan (scheduled) filing $8.4M
  5. SELLHoge Stephen, President sold Sep 15, 2026 40,281 shares 10b5-1 plan (scheduled) filing $5.9M
  6. SELLHoge Stephen, President sold Sep 14, 2026 40,294 shares 10b5-1 plan (scheduled) filing $5.8M
  7. SELLMock James M, Chief Financial Officer sold Sep 10, 2026 34,836 shares 2 legs combined 10b5-1 plan (scheduled) filing $4.7M
  8. SELLKlinger Shannon Thyme, Chief Legal Officer sold Sep 1, 2026 3,471 shares 10b5-1 plan (scheduled) filing $486K
  9. SELLBancel Stephane, Chief Executive Officer sold Aug 5, 2026 499,246 shares 4 legs combined 10b5-1 plan (scheduled) filing $28.7M
  10. SELLHoge Stephen, President sold Jul 15, 2026 53,336 shares 10b5-1 plan (scheduled) filing $3.6M
  11. SELLHoge Stephen, President sold Jun 15, 2026 53,336 shares 10b5-1 plan (scheduled) filing $2.7M
  12. SELLKlinger Shannon Thyme, Chief Legal Officer sold Jun 4, 2026 3,471 shares 10b5-1 plan (scheduled) filing $174K
  13. SELLAFEYAN NOUBAR sold May 21, 2026 9,263 shares filing $434K
  14. SELLHoge Stephen, President sold May 15, 2026 53,336 shares 10b5-1 plan (scheduled) filing $2.6M
  15. SELLHussain Abbas sold May 1, 2026 5,682 shares 10b5-1 plan (scheduled) filing $265K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Hoge Stephen filed Nov 17, 2026 Officer 39,215 shares planned sale date 11/17/2026 filing $8.3M
  2. Hoge Stephen filed Nov 16, 2026 Officer 39,160 shares planned sale date 11/16/2026 filing $8.6M
  3. Hoge Stephen filed Oct 15, 2026 Officer 39,145 shares planned sale date 10/15/2026 filing $8.6M
  4. Hoge Stephen filed Oct 14, 2026 Officer 39,224 shares planned sale date 10/14/2026 filing $8.4M
  5. Hoge Stephen filed Sep 15, 2026 Officer 40,281 shares planned sale date 09/15/2026 filing $5.9M
  6. Hoge Stephen filed Sep 14, 2026 Officer 40,294 shares planned sale date 09/14/2026 filing $5.8M
  7. Mock James M filed Sep 10, 2026 Officer 34,836 shares planned sale date 09/10/2026 filing $4.7M
  8. Klinger Shannon Thyme filed Sep 1, 2026 Officer 3,471 shares planned sale date 09/01/2026 filing $486K
  9. Bancel Stephane filed Aug 5, 2026 Officer 499,246 shares planned sale date 08/05/2026 filing $29.0M
  10. Hoge Stephen filed Jul 15, 2026 Officer 53,336 shares planned sale date 07/15/2026 filing $3.6M
  11. SAGAN PAUL filed Jun 18, 2026 Former Director 25,770 shares planned sale date 06/18/2026 filing $1.7M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. FMR LLC filed Nov 5, 2026 Schedule 13G/A passive 58,929,948 shares filing 14.8%
  2. Capital World Investors filed Aug 12, 2026 Schedule 13G passive filing 5.6%
  3. FMR LLC filed Aug 6, 2026 Schedule 13G/A passive 51,803,891 shares filing 13.1%
  4. BAILLIE GIFFORD & CO filed Jul 24, 2026 Schedule 13G/A passive 18,206,778 shares filing 4.6%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Purchase Oct 20, 2026 reported Nov 10, 2026 one of 65 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Maria Elvira Salazar (R-FL27): Sale Sep 24, 2026 reported Oct 7, 2026 one of 42 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  3. Rohit Khanna (D-CA17): Purchase Sep 11, 2026 reported Oct 7, 2026 one of 325 trades the member reported that day House owner: dependent $1,001 - $15,000
  4. Rohit Khanna (D-CA17): Purchase Aug 24, 2026 reported Sep 4, 2026 one of 178 trades the member reported that day House owner: spouse $1,001 - $15,000
  5. Maria Elvira Salazar (R-FL27): Purchase Aug 19, 2026 reported Sep 9, 2026 one of 12 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  6. Maria Elvira Salazar (R-FL27): Sale Aug 19, 2026 reported Sep 9, 2026 one of 12 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  7. Rohit Khanna (D-CA17): Purchase Jun 30, 2026 reported Jul 6, 2026 one of 375 trades the member reported that day House owner: spouse $1,001 - $15,000
  8. Rohit Khanna (D-CA17): Sale May 15, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: spouse $1,001 - $15,000
  9. Rohit Khanna (D-CA17): Sale May 1, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: dependent $1,001 - $15,000
  10. Rohit Khanna (D-CA17): Purchase Apr 13, 2026 reported May 11, 2026 one of 348 trades the member reported that day House owner: spouse $1,001 - $15,000
  11. Rohit Khanna (D-CA17): Sale Jan 29, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: spouse $1,001 - $15,000
  12. Rohit Khanna (D-CA17): Purchase Jan 23, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: dependent $1,001 - $15,000

Executive branch · OGE Form 278-T

Reported by the President

5 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Purchase: MODERNA INC Aug 28, 2026 reported Sep 17, 2026 President Donald J. Trump Periodic Transaction Report 09.17.26 $1,001 – $15,000
  2. Sale: MODERNA INC Aug 26, 2026 reported Sep 17, 2026 President Donald J. Trump Periodic Transaction Report 09.17.26 $15,001 – $50,000
  3. Purchase: MODERNA INC Aug 24, 2026 reported Sep 17, 2026 President Donald J. Trump Periodic Transaction Report 09.17.26 $1,001 – $15,000
  4. Sale: MODERNA INC May 18, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  5. Purchase: MODERNA INC Mar 17, 2026 reported May 8, 2026 President Donald J. Trump Periodic Transaction Report 05.08.26 (1) $1,001 – $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Entry into a material definitive agreement; Creation of a direct financial obligation filing Nov 16, 2026
  2. Departure or appointment of directors or officers filing Nov 13, 2026
  3. Results of operations and financial condition filing Nov 6, 2026
  4. Departure or appointment of directors or officers; Regulation FD disclosure filing Sep 30, 2026
  5. Entry into a material definitive agreement; Creation of a direct financial obligation; Unregistered sales of equity securities; Other events filing Sep 1, 2026
  6. Results of operations and financial condition filing Jul 31, 2026
  7. Departure or appointment of directors or officers; Regulation FD disclosure filing Jul 8, 2026

Lobbying · Senate LDA reports

Lobbying filed

10 quarterly lobbying reports for 2026 naming Moderna, Inc. as the client: 2 filed by the company itself, 8 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.

  1. The company itself Q2 2026 filing $290K
  2. HEALTH POLICY SOURCE, INC. Q2 2026 filing $100K
  3. BROWNSTEIN HYATT FARBER SCHRECK, LLP Q2 2026 filing $80K
  4. AVENUE SOLUTIONS Q2 2026 filing $50K
  5. HOLLAND & KNIGHT LLP Q2 2026 filing $20K
  6. The company itself Q1 2026 filing $190K
  7. BROWNSTEIN HYATT FARBER SCHRECK, LLP Q1 2026 filing $80K
  8. HEALTH POLICY SOURCE, INC. Q1 2026 filing $80K
  9. AVENUE SOLUTIONS Q1 2026 filing $50K
  10. HOLLAND & KNIGHT LLP Q1 2026 filing $20K

Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.